Healthequity Inc 's Revenue in the fiscal year 2026 $ 1,313.12 millions
Healthequity Inc 's Revenue in the fiscal year 2025 $ 1,199.26 millions
Healthequity Inc 's Revenue in the fiscal year 2024 $ 998.64 millions
Healthequity Inc 's Revenue in the fiscal year 2023 $ 861.75 millions
Healthequity Inc 's Revenue in the fiscal year 2022 $ 756.56 millions
HQY Revenue second quarter 2027 Y/Y Growth Comment
Healthequity Inc reported Revenue growth of 7.72% year on year in the second quarter 2027, to $ 350.73 millions, this is lower than Healthequity Inc 's recent average Revenue surge of 787.55%.
Looking into second quarter 2027 results within Professional Services industry 70 other companies have achieved higher Revenue growth. While Healthequity Inc ' s Revenue increase of 7.72% ranks overall at the positon no. 2253 in the second quarter 2027.
Revenue by Quarter for the Fiscal Years 2024, 2025, 2026, 2027
Healthequity Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
81.38 %
6.78 %
-7.35 %
(Oct 31 2019)
HQY's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2027 Healthequity Inc disclosed decrease in Revenue from the first quarter by -1.01% to $ 350.73 millions, from $ 354.31 millions achived in the previous reporting period.
But that's not important problem, as Healthequity Inc 's Revenue generally seem to plunge in this quarter.
Within Professional Services industry 68 other companies have achieved higher Revenue quarter on quarter growth. While Healthequity Inc 's Revenue growth quarter on quarter, overall rank is 1965.
In the II. Quarter 2027 Healthequity Inc disclosed decrease in Revenue from the first quarter by -1.01% to $ 350.73 millions, from $ 354.31 millions achived in the previous reporting period.
But that's not important problem, as Healthequity Inc 's Revenue generally seem to plunge in this quarter.
Within Professional Services industry 68 other companies have achieved higher Revenue quarter on quarter growth. While Healthequity Inc 's Revenue growth quarter on quarter, overall rank is 1965.
Healthequity Inc 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Jul 31 2026)
12 Months Ending (Apr 30 2026)
12 Months Ending (Jan 31 2026)
12 Months Ending (Oct 31 2025)
12 Months Ending (Jul 31 2025)
Cumulative Revenue 12 Months Ending
$ 1,361.69
$ 1,336.56
$ 1,312.56
$ 1,289.79
$ 1,267.75
Y / Y Revenue Growth (TTM)
7.41 %
7.68 %
9.56 %
12.29 %
15.57 %
Year on Year Revenue Growth Overall
Ranking
# 989
# 886
# 740
# 733
# 711
Seqeuential Revenue Change (TTM)
1.88 %
1.83 %
1.77 %
1.74 %
2.14 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 2253
# 1834
# 2201
# 1605
# 1387
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jul 31 2026 period, Healthequity Inc 's cumulative twelve months Revenue were $ 1,362 millions, company would post below average annual Revenue growth of 2.14% year on year, if the fiscal year would end at Jul 31 2026. A slow-down in the Healthequity Inc 's Revenue growth from the 354.31% growth in Apr 30 2026.
In the Services sector 95 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 886 to 989.
With the quarterly Revenue reported in the Jul 31 2026 period, Healthequity Inc 's cumulative twelve months Revenue were $ 1,362 millions, company would post below average annual Revenue growth of -27.69% year on year, if the fiscal year would end at Jul 31 2026. A slow-down in the Healthequity Inc 's Revenue growth from the 354.31% growth in Apr 30 2026.
In the Services sector 95 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 886 to 989.
About Healthequity Inc Revenue Growth Rates (HQY), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
11.21%